About the Company
electroCore, Inc. (Nasdaq: ECOR) is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD. The current chief executive officer is Daniel S. Goldberger. electroCore has one product called gammaCore, a non-invasive, commercially available product that uses vagus nerve stimulation.
Sector
Industrial Applications and Services
Industry
Electromedical & Electrotherapeutic Apparatus
Employees
73
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on electroCore, Inc.
electroCore, Inc. Announces Acquisition of NeuroMetrix, Inc. to Enhance ...
electroCore, Inc. Announces Acquisition of NeuroMetrix, Inc. to Enhance Bioelectronic Health and Wellness Offerings with Quell® Platform December 17, 2024 — 04:13 pm EST ...
electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of Truvaga
ROCKAWAY, N.J., Aug. 12, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine ...
Earnings To Watch: electroCore Inc (ECOR) Reports Q2 2025 Result
ElectroCore Inc (NASDAQ:ECOR) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate for Q2 2025 ...
electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates
Core, Inc. (ECOR) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to a loss of $0.38 per share a year ago. These figures are ...
electroCore, Inc. to Present at Upcoming Investor Conferences ... - Nasdaq
electroCore, Inc. announced its participation in upcoming investor conferences, including the Needham 10th Annual Virtual MedTech and Diagnostics Conference on August 11-12 and the Canaccord ...
electroCore Inc. R (43E0.BE) - Yahoo Finance
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025 ROCKAWAY, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq ...
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to ...
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health and promoting general wellness through its non-invasive vagus nerve stimulation ...
Electrocore Inc. | BioWorld
TORONTO – For Scott Kadwell, president of Markham, Ontario-based RSK Medical Inc., the distributor tagged to sell the Health Canada approved Gammacore Sapphire, the device represents “a shift from a ...
electroCore, Inc. Announces Distribution Agreement with Joerns ...
ROCKAWAY, N.J., Nov. 01, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that gammaCore Sapphire™, the first and ...
electroCore, Inc. Celebrates Veterans and Active Members of the ...
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused ...
electroCore, Inc. Announces Inclusion of gammaCore Sapphire™ in new ...
electroCore, Inc. Announces Inclusion of gammaCore Sapphire™ in new NHS England and NHS Improvement MedTech Funding Mandate Policy 2021/22 PRESS RELEASE GlobeNewswire Jan. 27, 2021, 08:00 AM ...
Similar Companies
Loading the latest forecasts...